HOW IS PEYRONIE´S DISEASE TREATED?

International Society for Sexual Medicine “How is Peyronie’s disease treated?” ANDROPEYRONIE (MEDICAL PEYRONIE EXTENDER)

Traction Therapy for Peyronie's Disease | ISSM
sex-health-brief}www.issm.info

Traction therapy following surgery for Peyronie’s disease may increase actual and perceived penile length for some men, according to new research published in the Journal of Sexual Medicine.

Peyronie’s disease, a wound-healing disorder, causes areas of hardened scar tissue called plaques to form on the penis. These plaques lead to decreased flexibility, resulting in a noticeable penile curvature during erection. Some men with Peyronie’s disease experience pain and are unable to have intercourse.

Surgery is one treatment option. Two types of surgeries pertain to this study. The first is called tunica albuginea plication (TAP) and involves stitching the area on the opposite side of the plaques to straighten the curvature. The other procedure is partial plaque excision and grafting (PEG), in which a surgeon makes an incision in the plaque and fills it with graft material.

One common complication of surgery for Peyronie’s disease is penile shortening, which can be a serious concern.

In this study, American researchers from Rush University Medical Center in Chicago worked with four groups of men. (A total of 134 men participated.) Two groups had TAP surgery, the other two had PEG procedures. For each type of surgery, one group had traction therapy and the other did not.

Traction therapy ( ANDROPEYRONIE ) involved wearing a traction device on the penis for a recommended 2–6 hours each day starting 3–4 weeks after surgery. From that point, patients were advised to use the device for three months. The goal of traction therapy (ANDROPEYRONIE) was to keep the penis straight as it healed and prevent length loss.

Stretched penile length measurements were taken before and after treatment. In addition, all men were mailed a questionnaire that asked about their perceptions of penile length change and their pre- and post-surgery satisfaction.

For the men who underwent TAP :

• The mean length change was 0.85 cm.

• 68% perceived erect length gain.

• 0% perceived erect length loss.

• 32% perceived no change in erect length.

For men who underwent TAP without traction therapy:

• The mean length change was -0.53 cm.

• 7% perceived erect length gain.

• 79% perceived erect length loss.

• 14% perceived no change in erect length.

For men who underwent PEG and traction therapy ( ANDROPEYRONIE ):

• The mean length change for was 1.48 cm.

• 47% perceived erect length gain.

• 0% perceived erect length loss.

• 53% perceived no change in erect length.

For men who underwent PEG without traction therapy:

• The mean length change was 0.24 cm.

• 14% perceived erect length gain.

• 57% perceived erect length loss.

• 29% perceived no change in erect length.

Overall, 69% of all participants were satisfied with their surgical outcome.

There were no complications or changes in penile sensation associated with traction therapy.

The researchers concluded that traction therapy can preserve some measured and perceived penile length after surgery for Peyronie’s disease. However, because of the psychological implications of penile length and outcome satisfaction, it is important for men to have realistic expectations before they have surgery.

Resources

International Society for Sexual Medicine

“How is Peyronie’s disease treated?”

http://www.issm.info/sexual-health-qa/how-is-peyronies-disease-treated

Journal of Sexual Medicine

Rybak, James, MD, et al.

“A Retrospective Comparative Study of Traction Therapy vs. No Traction Following Tunica Albuginea Plication or Partial Excision and Grafting for Peyronie’s Disease: Measured Lengths and Patient Perceptions”

(Full-text. First published online: August 17, 2012)

http://onlinelibrary.wiley.com/doi/10.1111/j.1743-6109.2012.02849.x/abstract

Andropeyronie Study Demonstrates Successful Peyronie’s Disease Management

Andropeyronie Study Demonstrates Successful Peyronie’s Disease Management 

 Aug 12, 2018

[PRESSWIRE] New York, US – 12.08.14 — A unique medical study commissioned by Andromedical (andromedical.com) shows Acute Phase Peyronie’s Disease can be successfully managed with a Traction Device in a Non-randomized Prospective Controlled Trial, with Ultrasound Correlation.

Andromedical's research study saw 55 clients go through PTT for six months - in between January 2009 as well as likewise October 2011 - compared to 41 people with AP of PD who did not get energetic treatment, over the very same period.More than 8 doctors from the Urology and also Radiology divisions of three leading Spanish health centers participated in the test, which saw penile grip treatment (PTT) used using a penile extender gizmo (PED), called Andropeyronie, for the treatment of clients in the acute stage (AP) of Peyronie's condition (PD).

The research study - whose purpose was to identify the efficiency as well as safety of using a PED - had the ability to wrap up that "PTT appears an effective treatment for the AP of PD in terms of discomfort reduction, penile curvature reduction, as well as improvement in sex-related function."

Peyronie's condition (PD) is a persistent wound recuperation disorder qualified by development of coarse inelastic mark of the tunica albuginea adhering to injury of the penis along with causing a range of defects containing curvature, shortening, narrowing, as well as additionally joint flaw.

It is related to a variable level of impotence (ED), which significantly affects the lifestyle of the customer and also is an issue that stands for a barrier to deal with.

For the total details of the research study along with its findings, please download the paper, right below:

http://www.andromedical.com/pdf/en/martinez-salamanca-jsm.pdf

http://www.ncbi.nlm.nih.gov/pubmed/24261900/

Worrying Andromedical

Andromedical is a medical firm for urology solutions and additionally manly sexuality headquartered in Madrid, Spain with offices in New York City. It was founded in 2000, after 4 years of specialist as well as also clinical study with the partnership of its CEO, Doctor Eduardo A. Gómez de Diego, and additionally his clients.

Andromedical research laboratory has a profile of clinical tools to manage impotence, penis enhancement, Peyronie ´ s illness and also post-surgery penile retraction in addition to in addition supplies erection high quality display screens.

Andromedical operates at a worldwide level, offering its items in over more than 165 nations. It has actually obtained a high degree of knowledge that makes it a market leader thanks to its major budget friendly advantage; Certified Medical Quality: which makes certain the effectiveness and also security of its items.

Contact

For more information, contact: support@andromedical.com

peyronie´s disease andropeyronie

The original
ANDROPENIS (20 years) is the only FDA registered  and patented penis
extender device sold in the US https://www.andromedical.com/andropenis/medical-penis-extender/
#penisextender #enlargepenis #bigpenis #penisenlargement, peyronie, andropenis
Be careful dont buy fakes¡

Controversies in Sexual Medicine: Is There a Place for Conservative Treatment in Peyronie’s Disease?

ABSTRACT

Introduction. Peyronie’s disease (PD) is a relatively common disorder affecting middle aged men. Conservative nonsurgical treatments include oral, topical, and intra‐lesional pharmacotherapies, vacuum stretching, and mechanical traction. (Yoram Vardi ,Laurence A. Levine , Juza Chen, Konstantinos Hatzimouratidis)

peyronie´s disease

Methods. Four people with expertise and/or interest in the area of PD were asked to contribute their opinions with regard to the safety and efficacy of nonsurgical conservative treatments.

Main Outcome Measure. To provide food for thought, discussion, and possible further research in a poorly discussed area of sexual medicine.

Results. Of the four experts writing on the topic, one believes a combination of medical therapy and penile traction ( andropeyronie )has positive potential for curvature. Another feels that although medical therapies have potential to alleviate pain, there is little evidence to show that they help with curvature or that penile traction ( andropeyronie )helps. A third expert proposes dividing the disease into phases, where patients in the acute phase may benefit from conservative therapy, whereas patients whose disease is stable require surgical intervention. The last expert agrees that the therapy should depend on the stage of the disease, but believes like the first expert that there is a role for traction therapy for patients with stable disease.

Conclusion. There is a need for guidelines for nonsurgical therapies for patients with PD, but there is a paucity of evidence as to their efficacy. Vardi Y, Levine LA, Chen J, Hatzimouratidis K, and Sohn M. Is there a place for conservative treatment in Peyronie’s disease? J Sex Med 2016;

andropeyronie